Sung-Hwan Cho
Amministratore Delegato presso CHOA PHARMACEUTICAL CO., LTD.
Patrimonio netto: 2 M $ in data 30/04/2024
Profilo
Sung-Hwan Cho is currently the Vice Chairman & Co-Chief Executive Officer at ChoA Pharmaceutical Co., Ltd.
and the President & Chief Executive Officer at Medipharm.
He has an undergraduate degree from Korea University and a graduate degree from Chung-Ang University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2023 | 1 849 162 ( 5.97% ) | 2 M $ | 30/04/2024 |
Posizioni attive di Sung-Hwan Cho
| Società | Posizione | Inizio |
|---|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Amministratore Delegato | - |
Medipharm
 Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Amministratore Delegato | - |
Formazione di Sung-Hwan Cho
| Korea University | Undergraduate Degree |
| Chung-Ang University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Borsa valori
- Insiders
- Sung-Hwan Cho
